XT
NUVB icon

XTX Topco’s Nuvation Bio NUVB Stock Holding History

XTX Topco’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$987K Buy
230,106
+195,322
+562% +$1.09M 0.02% 1428
2025
Q4 		$312K Sell
34,784
-72,156
-67% -$447K 0.01% 2031
2025
Q3 		$396K Sell
106,940
-8,781
-8% -$23.9K 0.02% 1268
2025
Q2 		$226K Buy
115,721
+60,157
+108% +$125K 0.01% 1628
2025
Q1 		$97.8K Buy
55,564
+44,979
+425% +$102K 0.01% 1877
2024
Q4 		$28.2K Sell
10,585
-121,444
-92% -$313K ﹤0.01% 1989
2024
Q3 		$302K Buy
+132,029
New +$403K 0.02% 1179
2024
Q2 		– Sell
-174,490
Closed -$635K – 2295
2024
Q1 		$635K Sell
174,490
-69,750
-29% -$134K 0.09% 348
2023
Q4 		$369K Buy
244,240
+217,666
+819% +$280K 0.08% 467
2023
Q3 		$35.6K Sell
26,574
-6,979
-21% -$11.6K 0.01% 1317
2023
Q2 		$60.4K Sell
33,553
-16,021
-32% -$27.2K 0.01% 1218
2023
Q1 		$82.3K Sell
49,574
-328
-0.7% -$665 0.02% 1119
2022
Q4 		$95.8K Buy
+49,902
New +$101K 0.02% 1006
2022
Q3 		– Sell
-56,307
Closed -$182K – 1295
2022
Q2 		$182K Buy
+56,307
New +$246K 0.07% 490

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's NUVB Position: Q1 2026 in Review

XTX Topco increased its Nuvation Bio (NUVB) stake by 562% in Q1 2026, buying an estimated $1.09M and bringing the position to 230,106 shares worth $987K. The position accounts for 0.02% of the portfolio, ranked #1428.

XTX Topco first reported a position in NUVB in Q2 2022 and has held it in 14 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • XTX Topco held 230,106 shares of Nuvation Bio worth $987K as of Q1 2026.
  • XTX Topco bought 195,322 Nuvation Bio shares in Q1 2026, an estimated $1.09M.
  • Nuvation Bio made up 0.02% of XTX Topco's portfolio in Q1 2026, its #1428 holding.
  • XTX Topco first reported a position in Nuvation Bio in Q2 2022 and has held it in 14 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.